International Journal of Head and Neck Surgery

Register      Login

VOLUME 8 , ISSUE 2 ( April-June, 2017 ) > List of Articles

INVITED REVIEW

High-risk Cutaneous Squamous Cell Carcinoma

C Fitzgerald, James Paul O'Neill

Citation Information : Fitzgerald C, O'Neill JP. High-risk Cutaneous Squamous Cell Carcinoma. Int J Head Neck Surg 2017; 8 (2):37-44.

DOI: 10.5005/jp-journals-10001-1304

License: CC BY 3.0

Published Online: 00-06-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Fitzgerald C, O'Neill JP. High-risk Cutaneous Squamous Cell Carcinoma. Int J Head Neck Surg 2017;8(2):37-44.


PDF Share
  1. Cutaneous squamous-cell carcinoma. N Engl J Med 2001 Mar;344(13): 975-983.
  2. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015 Oct;151(10):1081-1086.
  3. Human papillomavirus types detected in skin warts and cancer differ in their transforming properties but commonly counteract UVB induced protective responses in human keratinocytes. Virology 2014 Nov;468-470:647-659.
  4. Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. Nat Genet 2014 Oct;46(10):1060-1062.
  5. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008 Aug;9(8):713-720.
  6. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006 Jun;106(11):2389-2396.
  7. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005 Sep;115(9):1561-1567.
  8. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol 2010 Apr;3(4):39-48.
  9. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011 Jun;64(6):1051-1059.
  10. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Squamous Cell Skin Cancer. National Comprehensive Cancer Network, 2016.
  11. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol 2013 Apr;149(4):402-410.
  12. AJCC Cancer Staging Manual. 7th ed. 2010.
  13. AJCC Cancer Staging Manual. 8th ed. 2016.
  14. Evaluation of the definitions of “high-risk” cutaneous squamous cell carcinoma using the American Joint Committee on cancer staging criteria and national comprehensive cancer network guidelines. J Skin Cancer 2014;2014:154340.
  15. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol 2014 Feb 1;32(4):327-334.
  16. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002 Mar;28(3):268-273.
  17. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: A systematic review and meta-analysis. JAMA Dermatol 2016 Apr;152(4):419-428.
  18. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992 Jun;26(6):976-990.
  19. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 1997 Mar;79(5):915-919.
  20. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005 Feb;23(4):759-765.
  21. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg 2012 Apr;82(4):230-233.
  22. Cutaneous head and neck SCCs and risk of nodal metastasis — UK experience. J Craniomaxillofac Surg 2009 Dec;37(8):443-447.
  23. Evaluation of the American Joint Committee on cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg 2005;31(11 Pt 1):1379-1384.
  24. The effect of differentiation grade of cutaneous squamous cell carcinoma on excision margins, local recurrence, metastasis, and patient survival: A retrospective follow-up study. Ann Plast Surg 2015 Sep;75(3):323-326.
  25. Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression. Neoplasia 2015 Mar;17(3):301-305.
  26. Acantholytic squamous cell carcinoma: pathological study of nine cases with review of literature. Rom J Morphol Embryol 2014;55(2):279-283.
  27. [Desmoplastic squamous epithelial carcinoma of the skin and lower lip. A morphologic entity with great risk of metastasis and recurrence]. Hautarzt 1998 Feb;49(2):104-108.
  28. Squamous cell carcinoma of the skin — histopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol 1998 Jul;11(1):37-44.
  29. Desmosomal defects in acantholytic squamous cell carcinomas. J Cutan Pathol 2014 Nov;41(11):873-879.
  30. Adenosquamous carcinoma of the skin: a report of 10 cases. J Cutan Pathol 1991 Aug;18(4):227-234.
  31. Basosquamous carcinoma: is it an aggressive tumor? J Plast Surg Hand Surg 2015 Apr;49(2):107-111.
  32. Carcinoma arising in Bowen's disease. Arch Dermatol 1986 Oct;122(10):1124-1126.
  33. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998 Jun;124(6):637-640.
  34. Carcinoma of the skin with perineural invasion. Head Neck 2003 Dec;25(12):1027-1033.
  35. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg 2009 Apr;35(4):574-585.
  36. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg 2009 Dec;35(12):1859-1866.
  37. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012 Dec;106(7):811-815.
  38. Lymph node metastases from auricular squamous cell carcinoma. A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2008 Oct;61(10):1140-1147.
  39. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck 2006 Sep;28(9):785-791.
  40. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013 May;149(5):541-547.
  41. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy. J Am Acad Dermatol 2015 Aug;73(2):221-217.
  42. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 2010 Aug;25(8):2764-2771.
  43. I.G.N. Management of primary cutaneous squamous cell carcinoma: a national clinical guideline. 2014.
  44. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol 2008 Jul;159(1):198-204.
  45. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines in Oncology. Head Neck 2017 Mar;39(3):578-594.
  46. Incidence of incomplete excision in surgically treated cutaneous squamous cell carcinoma and identification of the related risk factors. Acta Med Iran 2011;49(12):806-809.
  47. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners. Arch Dermatol 2009 Nov;145(11):1253-1260.
  48. Guidelines for the excision of cutaneous squamous cell cancers in the United Kingdom: the best cut is the deepest. J Plast Reconstr Aesthet Surg 2013 Apr;66(4):467-471.
  49. Clinical and histological findings in re-excision of incompletely excised cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2009 Apr;62(4):457-461.
  50. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002 May;24(5):417-422.
  51. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 2010 Mar 1;116(5):1298-1304.
  52. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001 Mar;49(4):1061-1069.
  53. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992 Aug;27(2 Pt 1):241-248.
  54. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003 Mar;56(2):85-91.
  55. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer 2015 Sep;51(14):1989-2007.
  56. Prognostic factors for squamous cell cancer of the parotid gland: an analysis of 2104 patients. Head Neck 2015 Jan;37(1):1-7.
  57. Sentinel lymph node biopsy. BMJ 2004;328(7452):1330-1331.
  58. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005 Oct;23(30):7703-7720.
  59. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014 Feb;370(7):599-609.
  60. Utility of head and neck cutaneous squamous cell carcinoma sentinel node biopsy: a systematic review. Otolaryngol Head Neck Surg 2014 Feb;150(2):180-187.
  61. Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol 2015 Feb;41(2):197-200.
  62. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. JAMA Dermatol 2014 Jan;150(1):19-24.
  63. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 2006 Nov;32(11):1309-1321.
  64. Patterns of regional metastasis in advanced stage cutaneous squamous cell carcinoma of the auricle. Otolaryngol Head Neck Surg 2011 Jan;144(1):36-42.
  65. Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis. Eur Arch Otorhinolaryngol 2014 Nov;271(11):3011-3019.
  66. Pathologic occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid. Otolaryngol Head Neck Surg 2011 Apr;144(4):549-551.
  67. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg 2003 Sep;73(9):692-696.
  68. Neck dissection of level IIb: is it really necessary? Laryngoscope 2005 Sep;115(9):1624-1626.
  69. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol 2007 Apr;2007(3):80572.
  70. The role of parotidectomy in the treatment of auricular squamous cell carcinoma. Otolaryngol Head Neck Surg 2015 Jun;152(6):1048-1052.
  71. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005 Aug;53(2):253-260.
  72. Mohs surgery for squamous cell carcinoma. Dermatol Clin 2011;29(2):161-174, vii.
  73. Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010 Oct;36(10):1544-1553.
  74. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ 2013 Nov;347:f6153.
  75. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery. Dermatol Surg 2012 Jun;38(9):1456-1460.
  76. Relevance of dermatologic radiotherapy in the therapeutic strategy of skin epithelial neoplasms: excellent results in the treatment of lesions localized on eyelids and skin overlying the cartilage of the nose. G Ital Dermatol Venereol 2013 Feb;148(1):83-88.
  77. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980-1997. Australas Radiol 2001;45(2):195-199.
  78. Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma. Australas Radiol 2005 Oct;49(5):365-376.
  79. Early-stage squamous cell carcinoma of the lip: the Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection. Head Neck 2013 Oct;35(10):1426-1430.
  80. Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): The Roswell Park experience and a review of the literature. Am J Clin Oncol 2016 Dec;39(6):545-548.
  81. Chemotherapy of squamous cell carcinoma of the skin. Semin Oncol 2012 Apr;39(2):145-149.
  82. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer 1990 Oct;66(8):1692-1696.
  83. Clinical implementation of a new electronic brachytherapy system for skin brachytherapy. J Contemp Brachytherapy 2015 Jan;6(4):417-423.
  84. Dosimetric characteristics of a new unit for electronic skin brachytherapy. J Contemp Brachytherapy 2014 Mar;6(1):45-53.
  85. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013 Mar-Apr;12(2):134-140.
  86. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 2001;202(3):203-206.
  87. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. Pathol Res Pract 2011 Jun;207(6):337-342.
  88. The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target. Australas J Dermatol 2014 Feb;55(1):24-34.
  89. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005 Dec;23(34):8646-8654.
  90. Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Ann Oncol 2014 Oct;25(10):2047-2052.
  91. Immuno-regulatory antibodies for the treatment of cancer. Expert Opin Biol Ther 2015 Jun;15(6):787-801.
  92. Practical Approaches to Immunotherapy in the Clinic. Semin Oncol 2015 Dec;42 (Suppl 3):S20-S27.
  93. Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. J Clin Oncol 2014 Jul;32(19):e69-e71.
  94. Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol 2013 Dec;49(12):1089-1096.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.